Zara et al. showed promising results with the administration of an ibuprofen and lipoic acid conjugate to rats suffering from Alzheimer's disease, promoting the maintenance of Ngb levels that were similar to the control group, enabling Ngb to perform neuroprotective and survival-promoting actions [53]. This evidence concerns the gene NGB and early-onset autosomal dominant Alzheimer disease.